Background
Reducing injecting frequency
may reduce the risk of HIV infection and improve health outcomes among
injection drug users (IDU). However, the reduction of one risk behavior may be
associated with an increase in other risk behaviors, including the use of other
risk-associated substances. Our objective was to determine if an association
exists between a reduction in injecting and level of alcohol use among IDU.
Methods
We conducted a longitudinal
analysis of data collected for a randomized controlled trial examining the
efficacy of a peer education intervention in reducing HIV risk among IDU and
their network members in Thai Nguyen, Vietnam. Our analysis included active
male injectors (n=629) who were study participants and attended both baseline
and 3-month visits. Frequency of alcohol consumption was assessed as the number
of alcoholic drinks in the past 30 days. Change in risk and outcome behaviors
was calculated as the difference in frequencies of behaviors between baseline
and 3-month follow-up visits. The outcome of interest was concurrent decreased
drug injection and increased alcohol consumption.
Results
The mean difference between
baseline and 3-month follow-up of alcohol consumption and injection frequency
in the past 30 days was 19.03 drinks (93.68 SD) and 20.22 injections (35.66
SD), respectively. Participants who reported reduced injection frequency were
almost three times as likely to report increased alcohol consumption (OR 2.8;
95% CI, 2.0, 4.0). The proportion that both decreased injecting and increased
alcohol by any amount in the past 30 days was 35.6%. In multivariate analysis
higher education was significantly associated with an increase in alcohol and
decrease in injecting of any amount.
Conclusion
Male IDU may be at risk for
increasing alcohol consumption when they reduce injection frequency.
Interventions with male IDU that encourage reduction of injection may need to
review specific strategies to limit alcohol consumption.
Below: Change in # days consumed alcohol (y-axis) by Change in # days injected drugs (x-axis), in past 3 months: Visit2 – Visit1 = (3 months – Baseline).
Full article at: http://goo.gl/quESju
By: Vivian F.
Go,a,* Nguyen Le
Minh,b Constantine
Frangakis,c Tran Viet
Ha,a Carl A.
Latkin,d Teerada
Sripaipan,a Wendy
Davis,a Carla
Zelaya,a Nguyen
Phuong Ngoc,b and Vu Minh
Quana
aJohns Hopkins Bloomberg School of Public
Health, Department of Epidemiology, 615 N. Wolfe St. Baltimore, Maryland 21205
USA
bThai Nguyen Center for Preventive
Medicine, Thai Nguyen, Vietnam
cJohns Hopkins Bloomberg School of Public Health, Department
of Biostatistics, 615 N. Wolfe St. Baltimore, Maryland 21205 USA
dJohns Hopkins Bloomberg School of Public
Health, Department of Health, Behavior and Society, 624 N. Broadway, Baltimore,
Maryland 21205 USA
Corresponding Author: Vivian F. Go, PhD, MPH, Department of
Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe
Street, E6610, Baltimore, MD 21205, USA, Phone: 1-215-572-5736, Fax:
1-215-616-2334, Email: ude.hpshj@ogv
More at: https://twitter.com/hiv insight
No comments:
Post a Comment